Segment Information (Depreciation and Amortization by Reportable Segment) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting Information
Depreciation and amortization	$ 459	$ 397	$ 325
Pharmaceutical
Segment Reporting Information
Depreciation and amortization	128	125	114
Medical
Segment Reporting Information
Depreciation and amortization	130	137	119
Corporate
Segment Reporting Information
Depreciation and amortization	$ 201	$ 135	$ 92

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Name:	us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration